Skip to main content
Premium Trial:

Request an Annual Quote

Gualberto Ruano

Premium

Genaissance founder Gualberto Ruano has launched a new company, Genomas, which will focus on finding pharmacogenomic links to fitness and eating habits, according to the Hartford Courant. Ruano, 44, resigned from Genaissance on Aug. 31 after being ousted from the chief executive’s slot one year ago. He had served as the firm’s CSO since then. Genomas is self-funded and is based in Ruano’s home.

Filed under

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.